Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Use-results survey of Erwinase for Intramuscular Injection 10000
jRCT2031230366Recruiting
- Sponsor
- Ohara Pharmaceutical Co., Ltd.
- Start
- Sep 2023
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of Asparaginase in Acute Leukaemia, acute lymphoblastic leukemia (ALL) and lymphoma, sponsored by Ohara Pharmaceutical Co., Ltd. Primary endpoint: Safety (incidence of side effects and adverse events). Started Sep 2023; status: recruiting.
02
Drugs
Asparaginase
03
Conditions
Acute Leukaemiaacute lymphoblastic leukemia (ALL)lymphoma
Beyond the preview
Go deeper on jRCT2031230366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230366.